A disruption of GSH homeostasis could induce oxidative stress and lead to neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinsons disease, Alzheimers disease, and dementia, with impaired motor and cognitive functions [7]
You're seeing it almost every day, he says
PMCID: PMC8624542
While this study was not a head-to-head clinical trial comparison, it may be relevant that at week 12 of a weekly dosing regimen, some studies suggest that participants treated with semaglutide (Wegovy, Novo Nordisk) had an approximately 6% decrease from baseline in body weight, whereas those treated with tirzepatide (Zepbound, Eli Lilly) had an approximately 8% decrease from baseline in body weight at the same time period, Bays said
This allows them to lift heavy weights, protect their basal metabolic rate, and lose pure body fat rather than lean tissue
Buetow, L